Ideal Cures Receives Investment from TA Associates

Ideal Cures Private Limited, a supplier of ready-to-use coating products and excipients for tablets and capsules to the pharmaceutical and allied industries, received a private equity investment from TA Associates.

The financial terms of the transaction were not disclosed. In conjunction with the deal, Dhiraj Poddar, Country Head of India, TA Associates Advisory Private Limited, will join the Ideal Cures Board of Directors.

Founded in 1999 in India by Suresh Pareek, Managing Director, ald also led by Kamlesh Oza, President – Global Business Development, Ideal Cures is a manufacturer and exporter of pharmaceutical excipients and ready-to-use coating systems for solid oral dosage forms. Its products are used to provide aesthetic coatings as well as functional coatings for tablets and capsules. Aesthetic sugar or film coatings allow for swallowability and taste masking. They also aid brand recognition, authentication and differentiation. Functional coatings serve a number of purposes ranging from moisture, oxygen and light protection of drugs to controlling drug delivery to a specific part of the gastrointestinal tract.
The company also produces specialty excipients such as neutral pellets, cooling compounds, taste masking agents, controlled release polymer blends and pharma acrylic polymers.
Ideal Cures has three manufacturing plants located in Vasai, Jammu and Khambat; and two R&D facilities in Mumbai and Vasai. Another plant is under construction in Sikkim.



Join the discussion